As of 2025-05-28, the EV/EBITDA ratio of THC Farmaceuticals Inc (CBDG) is
-17.07.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CBDG's latest enterprise value
is 0.71 mil USD. CBDG's TTM EBITDA according to its financial statements is
-0.04 mil USD. Dividing these 2
quantities gives us the above CBDG EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
6.1x - 7.4x |
7.2x |
| Forward P/E multiples |
6.7x - 9.4x |
7.1x |
| Fair Price |
(0.04) - 0.29 |
0.08 |
| Upside |
-377.2% - 1933.5% |
496.6% |